NPI-0052 (a 2nd generation proteasome inhibitor) Phase 1 study in patients with lymphoma and solid tumors Meeting Abstract
| Authors: | Kurzrock, R.; Hamlin, P.; Gordon, M.; Hong, D.; Fu, S.; Younes, A.; Hannah, A.; Palladino, M. A.; Spear, M. A.; Aghajanian, C. |
| Abstract Title: | NPI-0052 (a 2nd generation proteasome inhibitor) Phase 1 study in patients with lymphoma and solid tumors |
| Meeting Title: | 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | EJC Supplements |
| Volume: | 6 |
| Issue: | 12 |
| Meeting Dates: | 2008 Oct 21-24 |
| Meeting Location: | Geneva, Switzerland |
| ISSN: | 1359-6349 |
| Publisher: | Pergamon-Elsevier Science Ltd |
| Date Published: | 2008-10-01 |
| Start Page: | 73 |
| End Page: | 74 |
| Language: | English |
| ACCESSION: | WOS:000261221200232 |
| DOI: | 10.1016/s1359-6349(08)72166-9 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: 234 - Poster - 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - OCT 21-24, 2008 - Geneva, SWITZERLAND - "Source: Wos" |
